A legacy of firsts

Kindeva was built on more than a century of scientific achievement, successfully moving from promise to patent more than 500 times, launching dozens of life-changing products with the commitment to solving the challenges that come our way during the process.

  • 1946

    William Riker founded the drug store that would become Riker Labs

  • 1956

    First metered dose inhaler (MDI)

  • 1970

    First drug-in-adhesive patch

  • 1989

    First breath-actuated inhaler

  • 1994

    First stand-alone 7-day drug-in-adhesive patch

  • 1995

    First CFC-free MDI

  • 2008

    First single-cycle FDA review

  • 2010

    First commercially available dose counter

  • 2012

    First CFC-free nasal MDI

  • 2015

    First bioequivalent alternative to combination asthma therapy in the UK

  • 2016

    Introduced the Intelligent Control Inhaler
    First generic transdermal product for Kindeva

  • 2018

    First commercial solid microsystems agreement signed

  • 2019

    Supplied Phase III clinical study for Solid Microsystems Abaloparatide Program

  • 2020

    Established as Kindeva Drug Delivery

 

Global reach

  • Global Headquarters

  • 11200 Hudson Road Woodbury, MN 55129, USA
  • State-of-the-Art R&D Facilities

  • Loughborough, UK
  • St. Paul, USA
  • cGMP Manufacturing Facilities

  • Loughborough, UK
  • Clitheroe, UK
  • Northridge, USA
  • St. Paul, USA
 

Leadership team

LinkedIn
˅
˄

Aaron Mann, Chief Executive Officer

Aaron has served as the Chief Executive Officer of Kindeva and as a member of the Board of Directors since the firm’s creation in May 2020, having previously led the same business inside 3M. Previously at 3M, he led strategy and acquisitions for the Health Care Business Group, completing $7B+ of transactions. He has also held multiple executive roles at private-equity–backed healthcare businesses (Phillips-Medisize, Remedi SeniorCare), and started his career as a strategy consultant with Bain & Company. He holds a BA in Economics from Carleton College, and an MBA from the Harvard Business School.

LinkedIn
˅
˄

Amber McKeague, VP of Human Resources

As Vice President of Human Resources, Amber leads Kindeva’s efforts for talent strategy in recruiting, organizational development and learning, benefits and compensation, payroll, employee relations, and compliance. Amber partners closely with the Kindeva leadership team to integrate human resources initiatives into strategic organizational goals. Prior to her role at Kindeva, Amber held multiple HR leadership roles at 3M and Curt Manufacturing. She holds a BA in Human Resource Management from Winona State University.

LinkedIn
˅
˄

Carl Brookes, VP of Manufacturing & Supply Chain Operations

As the Vice President of Manufacturing & Supply Chain operations, Carl leads a very talented Global Manufacturing and Supply Chain team for Kindeva Drug Delivery. He has held a number of roles and gained experience within Manufacturing Operations at 3M from Customer Services to Production Leadership to Manufacturing Site Management. He holds an MBA from the University of Derby.

LinkedIn
˅
˄

Katie DeCabooter, VP of IT & Continuous Improvement

As Vice President of Information Technology & Continuous Improvement, Katie leads our IT team including Infrastructure, Applications, and Data & Analytics. She also leads the Kindeva Continuous Improvement Black Belts who run and coach CI projects at all Kindeva sites. Prior to Kindeva, Katie held a variety of IT and Lean Six Sigma roles at 3M. She holds a BA in Computer Information Systems from St. Cloud State and an MBA from the University of Minnesota.

LinkedIn
˅
˄

Mike Ratigan, VP of Business Development, Sales, and Marketing

As Vice President of Business Development, Sales and Marketing, Microneedles, Mike leads Kindeva’s business development team that aggressively grows the pipeline. Mike comes with a career spent in drug delivery, with a particular focus on injectable delivery and devices. His commercial track record approaches $1B in total development, partnership and manufacturing agreements with global biopharmaceutical companies, primarily in injectable drug delivery device combination products.

LinkedIn
˅
˄

Nicholas Smalley, VP of Global Regulatory Affairs

As Vice President of Global Regulatory Affairs, Nicholas leads Kindeva’s Global Regulatory Affairs organization. Nicholas has held previous positions in Regulatory at 3M Health Care, Perrigo, UCB, and Norton Healthcare Limited. He holds a BA in Chemistry from Loughborough University.

LinkedIn
˅
˄

Raj Khankari, VP of Research and Development

As Vice President of Research and Development, Dr. Khankari brings 28 years of global experience in the pharmaceutical and drug delivery sectors.  Dr. Khankari has held senior leadership roles at multiple organizations. Most recently, he was CEO at RiboCor, Inc., and prior to that served as the General Manager / Vice President of Worldwide Drug Delivery Technologies at CIMA Labs/Cephalon. Dr. Khankari holds a Ph.D in Pharmaceutics and an MBA from the University of Minnesota, and a Masters in Pharmaceutics from the University of Cincinnati. 

LinkedIn
˅
˄

Robby McGarry, VP of Legal, General Counsel & Corporate Secretary

As the Vice President of Legal, General Counsel & Corporate Secretary, Robby leads Kindeva’s global legal function, providing legal guidance to all departments. Prior to Kindeva, Robby was a division counsel, supporting global healthcare businesses within 3M in the areas of medical devices, pharmaceuticals, and healthcare software. Prior to 3M, Robby worked as an attorney at the Minneapolis office of Dorsey & Whitney LLP. He holds a BA in Political Science and a BA in Sociology from the University of Minnesota, an MLS in Political Science, Sociology, and Cultural Studies from the University of Minnesota, and a JD from the University of Utah.

LinkedIn
˅
˄

Steve Fuechtmann, Chief Financial Officer

As the Chief Financial Officer, Steve brings 25+ years of progressive experience in Finance, Accounting, Treasury, IT, Operations and Strategic Planning to Kindeva. Throughout his career, Steve has demonstrated that he is a values-based leader who partners very closely with the businesses that he supports to drive transformational improvements in operational and financial performance. Steve graduated from St. John’s University in Collegeville, MN with a BA in Accounting and Management.

LinkedIn
˅
˄

Will Donovan, VP of Quality

As the Vice President of Quality, Will leads Kindeva’s efforts toward building Kindeva’s quality brand across the enterprise in partnership with our customers. Will brings 25 years of experience in quality and regulatory leadership roles in the healthcare industry prior to joining Kindeva. He holds a BS in Chemical Engineering and an MBA in Business Administration and Management.

 

Kindeva Careers

Inventive, curious, and committed to results? We’re hiring.

Explore Job Opportunities